media

Markets

Market Nav

AUROBINDO PHARMA LTD.

  • NSE CodeAUROPHARMAEQ
  • BSE Code524804
  • ISININE406A01037
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

26/12/1986

Registered Address

Registered Office : Plot No.2, Maitri Vihar, Ameerpet,
Hyderabad, Telangana - 500038
Tel: 040-23736370, 23747340
Fax: 040-23741080

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

info@aurobindo.com

Website

http://www.aurobindo.com

Listing

BSE, MCXSX, NSE

Corporate News

Aurobindo Pharma - Announcement under Regulation 30 (...

17-May-2024|11:37AM

Schedule of earning call to be held on May 27, 2024 at 8.30 AM on Audited F

Aurobindo Pharma - Analysts/Institutional Investor Me...

17-May-2024|11:30AM

Aurobindo Pharma Limited has informed the Exchange about Schedule of meet

Aurobindo Pharma - Board Meeting Intimation

16-May-2024|3:02PM

AUROBINDO PHARMA LIMITED has informed the Exchange about Board Meeting to b

Aurobindo Pharma - Board Meeting Intimation for Consi...

16-May-2024|2:56PM

AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Dire

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug51.00143.08
Aarti Drug487.804,484.59
Aarti Pharma615.155,574.86
Abbott India26,656.9056,644.05
Accent Micro328.00690.21

MF Holding

Scheme NameValue
(₹ Cr)
Holding (%)
HDFC Mi..1386.832.19
Quant M..608.248.79
Mirae A..571.801.63
Quant E..423.224.52
ICICI P..400.280.94

Board Meetings

DatePurpose
10/02/2024Quarterly Results &..
09/11/2023Quarterly Results &..
12/08/2023Quarterly Results
27/05/2023Audited Results
09/02/2023Quarterly Results &..